Papyrus Australia advanced its commercialisation with two critical milestones under its TBS contract and completed a multi-part capital raise, positioning the company for manufacturing scale-up.
- Executed binding board production contract with Vietnam manufacturer
- Delivered 200 biodegradable Collar Keeper samples for customer qualification
- Shareholders approved capital raising including share placements and convertible notes
- Adelaide R&D facility focused on pulp optimisation and scale production design
- Company ends quarter with $245k cash and $837k total available funding
Contract Milestones Advance Commercialisation
Papyrus Australia Ltd (ASX:PPY) marked significant progress in Q2 2026 by achieving the first two milestones under its contract with TBS Mining Solutions. The company executed a binding Board Production Contract with a Vietnam-based paperboard manufacturer, enabling the supply of its proprietary pulp for conversion into jumbo rolls. This milestone allows Papyrus to concentrate on scaling its fibre technology while outsourcing non-core processing.
Following this, Papyrus delivered 200 Biodegradable Collar Keeper® product samples to TBS, produced using commercial-scale equipment. This represented the first full-scale conversion of its agricultural-waste pulp into customer-ready paperboard, a crucial step for product qualification and testing.
R&D and Manufacturing Scale-Up Efforts Continue
The Adelaide Rapid Prototyping & R&D Facility remained a hub for product validation and development. Activities included pulp furnish optimisation aimed at producing high-strength board, ongoing production of customer evaluation materials, and engineering design work to support scale production. Preparations are underway to transition these developments into the manufacturing pathway.
Further validation of pulp performance on commercial-scale board-forming lines and refinement of board specifications for Collar Keeper® applications were conducted. Papyrus also engaged Hall Chadwick Melbourne Pty Ltd to assist in establishing high-volume production capabilities in Vietnam, signalling a clear focus on commercial readiness.
Capital Raising Secures Funding for Commercialisation
Financially, Papyrus advanced a multi-component capital raising program comprising a $175,000 share placement, $150,000 in new short-term director loans converted to shares, and the conversion of existing loans into secured and unsecured convertible notes totaling approximately $528,000. These funds are earmarked to support ongoing commercialisation activities and delivery under the TBS contract.
Shareholders ratified all resolutions at an Extraordinary General Meeting held on 24 June 2026, clearing the way for the capital raising to proceed. The company ended the quarter with cash and cash equivalents of $245,000 and $672,000 drawn from financing facilities, leaving total available funding of $837,000. This provides an estimated 2.1 quarters of runway based on recent operating cash flows.
Operational Costs and Cash Flow Dynamics
Quarterly expenditure primarily covered commercial board production trials, pulp processing, prototyping equipment installation, and operating costs of the R&D facility. Staff, legal, compliance, and overhead costs also contributed to cash outflows. Despite these outflows, Papyrus benefited from government grants and tax incentives, partially offsetting expenses.
The company reported no payments to related parties during the quarter, maintaining clear separation of operational and financing activities. Notably, $239,000 of cash held by its Egyptian subsidiary is restricted and not freely available.
Bottom Line?
Papyrus has laid solid groundwork with contract milestones and funding but must now translate these into sustained commercial production and customer acceptance.
Questions in the middle?
- How quickly will Papyrus convert its manufacturing scale-up plans into consistent commercial output?
- What are the terms and pricing expectations following the initial fixed-cost production trials with the Vietnam manufacturer?
- Will the current funding runway be sufficient to reach cash flow breakeven or will further capital raising be necessary?